Commentary · 27 May 2026
Review articlePublished 2013
Notch Signaling Pathway in Pancreatic Cancer Progression
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pancreatic cancer (PC) is one of the highly aggressive malignances in the United States, suggesting that novel treatment strategies are required to achieve better treatment outcome in PC patients. To achieve this goal, elucidation of underlying mechanism of development and progression of PC is necessary. Although the molecular causes of PC are largely elusive, many studies have demonstrated that multiple critical genes including K-ras, p53, p16, and other key cellular signaling pathways such as PI3K/Akt, mammalian target of rapamycin (mTOR), nuclear factor-kappa B (NF-κB), epidermal growth factor receptor (EGFR), and sonic hedgehog (SHH) plays important roles in the pancreatic tumorigenesis.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pancreatic Disorders & Therapy.
Short communication · 27 May 2026
Immunometabolic Interactions in Pancreatic Disease: Crosstalk Between Energy Dysregulation, Immune Activation, and Tissue Dysfunction
Commentary · 27 May 2026
Microvascular Dysfunction in Pancreatic Disorders: Endothelial Injury, Perfusion Failure, and Tissue Consequences
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPancreatic Disorders & Therapy
- SubjectGastroenterology & Hepatology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Jia Ma”
- BylineArticles whose byline prints “Jun Xia”
- BylineArticles whose byline prints “Lucio Miele”
- BylineArticles whose byline prints “Fazlul H Sarkar”
- BylineArticles whose byline prints “Zhiwei Wang”

